While AMPK activation by systemic IL-6 also corresponds with mTORC1 suppression in tumor-bearing mice [94], AMPK inhibition could rescue IL-6-induced suppression of mTORC1 signaling in C2C12 myotubes [94]. This evidence concerns the gene IL6 and neoplasm.